aCenter for Biostatistics in AIDS Research, Harvard T.H. Chan School of Public Health, Boston, MA;

bDepartment of Biostatistics, Collaborative Studies Coordinating Center, Gillings School of Public Health, University of North Carolina at Chapel Hill, Chapel Hill, NC;

cDepartment of Infectious Diseases, St. Jude Children's Research Hospital, Memphis, TN;

dDepartment of Psychology, San Diego State University, San Diego, CA;

eFrontier Science and Technology Research Foundation, Inc., Amherst, NY; and

fDepartment of Health Behavior and Health Education, School of Public Health, University of Michigan, Ann Arbor, MI.

Correspondence to: Jane C. Lindsey, Center for Biostatistics in AIDS Research, 651 Huntington Ave, Boston, MA 02115 (e-mail: [email protected]).

Supported in part by the Adolescent Medicine Trials Network for HIV/AIDS Interventions (ATN) from the National Institutes of Health (U24HD089880) through the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institute on Minority Health and Health Disparities (NIMHD), National Institute of Mental Health (NIMH), and National Institute on Drug Abuse (NIDA).

The authors have no conflicts of interest to disclose.

Presented at the 16th International Conference on HIV Treatment and Prevention Adherence; November 8, 2021; Miami, FL.

The content in this manuscript is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Clinical Trial Number: NCT03292432.

Supplemental digital content is available for this article. Direct URL citations appear in the printed text and are provided in the HTML and PDF versions of this article on the journal's Web site (www.jaids.com).